Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule
- PMID: 15128809
- DOI: 10.4049/jimmunol.172.10.6209
Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule
Abstract
Vaccines intended to prevent mucosal transmission of HIV should be able to induce multiple immune effectors in the host including Abs and cell-mediated immune responses at mucosal sites. The aim of this study was to characterize and to enhance the immunogenicity of a recombinant modified vaccinia virus Ankara (MVA) expressing HIV-1 Env IIIB Ag (MVAenv) inoculated in BALB/c mice by mucosal routes. Intravaginal inoculation of MVAenv was not immunogenic, whereas intranasally it induced a significant immune response to the HIV Ag. Intranasal codelivery of MVAenv plus cholera toxin (CT) significantly enhanced the cellular and humoral immune response against Env in the spleen and genitorectal draining lymph nodes, respectively. Heterologous DNAenv prime-MVAenv boost by intranasal immunization, together with CT, produced a cellular immune response in the spleen 10-fold superior to that in the absence of CT. A key finding of these studies was that both MVAenv/MVAenv and DNAenv/MVAenv schemes, plus CT, induced a specific mucosal CD8(+) T cell response in genital tissue and draining lymph nodes. In addition, both immunizations also generated systemic Abs, and more importantly, mucosal IgA and IgG Abs in vaginal washings. Specific secretion of beta-chemokines was also generated by both immunizations, with a stronger response in mice immunized by the DNA-CT/MVA-CT regimen. Our findings are of relevance in the area of vaccine development and support the optimization of protocols of immunization based on MVA as vaccine vectors to induce mucosal immune responses against HIV.
Similar articles
-
Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.Virus Res. 2006 Mar;116(1-2):11-20. doi: 10.1016/j.virusres.2005.08.008. Epub 2005 Oct 7. Virus Res. 2006. PMID: 16214252
-
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.J Virol. 2003 Jun;77(12):7048-57. doi: 10.1128/jvi.77.12.7048-7057.2003. J Virol. 2003. PMID: 12768024 Free PMC article.
-
Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.J Gen Virol. 2007 Jan;88(Pt 1):61-70. doi: 10.1099/vir.0.82216-0. J Gen Virol. 2007. PMID: 17170437 Free PMC article.
-
Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.Expert Rev Vaccines. 2017 Oct;16(10):973-985. doi: 10.1080/14760584.2017.1371594. Epub 2017 Sep 4. Expert Rev Vaccines. 2017. PMID: 28838267 Free PMC article. Review.
-
Development of a DNA-MVA/HIVA vaccine for Kenya.Vaccine. 2002 May 6;20(15):1995-8. doi: 10.1016/s0264-410x(02)00085-3. Vaccine. 2002. PMID: 11983261 Review.
Cited by
-
NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin.Front Immunol. 2018 Jan 24;8:1988. doi: 10.3389/fimmu.2017.01988. eCollection 2017. Front Immunol. 2018. PMID: 29416534 Free PMC article.
-
Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.Int J Cancer. 2011 Aug 1;129(3):762-72. doi: 10.1002/ijc.25973. Int J Cancer. 2011. PMID: 21384340 Free PMC article.
-
Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse transcription-PCR.Clin Vaccine Immunol. 2008 May;15(5):757-64. doi: 10.1128/CVI.00392-07. Epub 2008 Mar 26. Clin Vaccine Immunol. 2008. PMID: 18367582 Free PMC article.
-
The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice.J Med Virol. 2010 May;82(5):727-34. doi: 10.1002/jmv.21667. J Med Virol. 2010. PMID: 20336714 Free PMC article.
-
Every breath you take: the impact of environment on resident memory CD8 T cells in the lung.Front Immunol. 2014 Jul 8;5:320. doi: 10.3389/fimmu.2014.00320. eCollection 2014. Front Immunol. 2014. PMID: 25071780 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous